AstraZeneca May Not Stay in Vaccines, but CEO Has No COVID Regrets

AstraZeneca may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the first COVID-19 shots but has since lost out to rivals.
Reuters Health Information

source https://www.medscape.com/viewarticle/979613?src=rss

Comments

Post a Comment

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Rheumatoid arthritis increased the risk for lung cancer, and this risk was threefold higher in patients with rheumatoid arthritis–associated interstitial lung disease. Medscape Medical News source https://www.medscape.com/viewarticle/rheumatoid-arthritis-and-ra-associated-interstitial-lung-2024a1000epm?src=rss
Read more

New AAFP practice guideline sets blood pressure targets for adults with hypertension

From 1977 to 2003, seven Joint National Committees (JNC), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), produced consensus multi-specialty guidelines on the diagnosis and management of hypertension. In 2013, well into the development of JNC8, the NHLBI abruptly turned the process over to the American College of Cardiology/American Heart Association (ACC/AHA). The JNC8 committee independently published an evidence-based guideline in JAMA that raised the blood pressure treatment threshold in most older adults from 140/90 to 150/90 mm Hg. Concerned about conflicts of interest and other deviations from Institute of Medicine-recommended practices for developing trustworthy guidelines , primary care groups, including the American Academy of Family Physicians (AAFP), declined to participate in the ACC/AHA guideline panel. And the longstanding edifice of hypertension guidelines fractured. In 2017, the ACC/AHA released its clinical practice guideline , which most notab...
Read more

Heart Failure Care Outside of ICU Can Lower Cost

A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU is more cost effective, among other advantages. Medscape Medical News source https://www.medscape.com/viewarticle/heart-failure-care-outside-icu-can-lower-cost-2025a10006iy?src=rss
Read more